1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone) - Type2diabetes, Insulin Resistance | Phase 3 | Unknown | Nanjing First Hospital, Nanjing Medical University | 60 | 2022-11-01 | 2022-10-24 |
Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Metformin (1) · Pioglitazone (1) · dapagliflozin (1)